insights_auto
Why is OCUL up 4,17%?
Dive Deeperchevron_right
OCUL:NASDAQ
Ocular Therapeutix Inc
7,25 $
arrow_upward
+4,17%(+0,29) 1D
7,25 $
arrow_downward
-0,02% (-0,0016)bedtimeAfter hours
Closed: 5 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCUL...
Open
6,93 $
High
7,27 $
Low
6,79 $
Mkt. cap
1,59 մլրդ
Avg. vol.
2,97 մլն
Volume
5,62 մլն
52-wk high
16,44 $
52-wk low
6,23 $
EPS
-1,41 $
Beta
1,00
Shares outstanding
219,62 մլն
No. of employees
325
Open
6,93 $
High
7,27 $
Low
6,79 $
Mkt. cap
1,59 մլրդ
Avg. vol.
2,97 մլն
Volume
5,62 մլն
52-wk high
16,44 $
52-wk low
6,23 $
EPS
-1,41 $
Beta
1,00
Shares outstanding
219,62 մլն
No. of employees
325
News stories
From web sources and news partners
Simply Wall Street
·
7 րոպե առաջ
Two Stories Ran On Sarepta Therapeutics. Only One Held Up
24/7 Wall St.
·
42 րոպե առաջ
Forget JEPQ: Goldman's Nasdaq Income Fund Raised Its October Payout While JPMorgan Cut Its Own
Moomoo
·
14 րոպե առաջ
U.S. Treasury Sell-Off Fails to Halt Stock Rally; Three Major Indices Close Higher as Nasdaq Hits Record High
Yahoo Finance
·
45 րոպե առաջ
Goldman Sachs spills the beans on what’s next for S&P 500
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiteocutx.com